Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 26, 2019 - Issue 2
200
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

New sequence variants in patients affected by amyloidosis show transthyretin instability by isoelectric focusing

, , , , , & show all
Pages 85-93 | Received 04 May 2018, Accepted 19 Mar 2019, Published online: 10 May 2019
 

Abstract

The plasma protein transthyretin (TTR) can aggregate into insoluble amyloid fibrils causing systemic amyloidosis (ATTR amyloidosis) in patients carrying a variant TTR protein. If new variants arise, it is crucial to clarify whether they are disease-associated or benign. In this study, we further functionally characterize three new and unclassified TTR variants (Thr40Asn, Phe64Val and the described but not functionally assessed variant Leu12Val), using a simplified, fast isoelectric focusing (IEF) approach. After validating the system with known TTR variants, we assessed the sera of five patients carrying these new TTR variants in a heterozygous state. All three variants showed aberrant banding patterns that were similar to those of other well-characterized TTR variants, including the common Val30Met variant that causes ATTR amyloidosis. In addition to a clear band corresponding to monomeric wild-type TTR, we observed an additional variant band at the cathodal side of the IEF gel. These results indicate conformational instability of the new Thr40Asn, Phe64Val and Leu12Val variants. Together with the clinical and immunohistological data of these patients and affected family members, as well as the absence of these variants in human genetic mutation databases, our results strongly hint that these variants are amyloidogenic and therefore probably disease-associated. These findings have implications for patient therapy and for genetic counselling of family members.

Acknowledgements

We are indebted to Prof. Klaus Altland and Pia Winter for their support, equipment and helpful advice during the methodological setup and interpretation of the results. For the measurement of TTR serum levels, the authors wish to thank Dr. Markus Zorn. In addition, we thank SERVA Electrophoresis GmbH (Heidelberg) for their excellent technical support.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.